CLPUB00037
Freund M., Kleine H.-D., Lux E., Exeriede G., Hanauske A.-R., Herbst H., Vainchenker W., Schweigerer L., Fonatsch C., Poliwoda H.
ELF-153: a novel cell line derived from a patient with acute myelofibrosis and AML.
Blut 61:128-128(1990)

PubMed=7519473; DOI=10.1182/blood.V84.4.1085.1085
Mouthon M.-A., Freund M., Titeux M., Katz A., Guichard J., Breton-Gorius J., Vainchenker W.
Growth and differentiation of the human megakaryoblastic cell line (ELF-153): a model for early stages of megakaryocytopoiesis.
Blood 84:1085-1097(1994)

PubMed=7488550; PMCID=PMC1997200
Hassan H.T., Hanauske A.-R., Lux E., Kleine H.-D., Freund M.
A new fibroblast growth stimulating activity from the human megakaryoblastic leukaemia cell line ELF-153: in vitro and in vivo findings.
Int. J. Exp. Pathol. 76:361-367(1995)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

PubMed=16408098; DOI=10.1038/sj.leu.2404081
Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.
Leukemia 20:471-476(2006)

PubMed=31160637; DOI=10.1038/s41598-019-44491-x; PMCID=PMC6547646
Quentmeier H., Pommerenke C., Dirks W.G., Eberth S., Koeppel M., MacLeod R.A.F., Nagel S., Steube K.G., Uphoff C.C., Drexler H.G.
The LL-100 panel: 100 cell lines for blood cancer studies.
Sci. Rep. 9:8218-8218(2019)